Abstract:Alzheimer's disease (AD), a multi-factorial neurodegenerative disorder has affected over 30 million individuals globally and these numbers are expected to increase in the coming decades. Current therapeutic interventions are largely ineffective as they focus on a single target. Development of an effective drug therapy requires a deep understanding of the various factors influencing the onset and progression of the disease. Aging and genetic factors exert a major influence on the development of AD. Other factors like post-viral infections, iron overload, gut dysbiosis, and vascular dysfunction also exacerbate the onset and progression of AD. Further, post-translational modifications in tau, DRP1, CREB, and p65 proteins increase the disease severity through triggering mitochondrial dysfunction, synaptic loss, and differential interaction of amyloid beta with different receptors leading to impaired intracellular signalling. With advancements in neuroscience tools, new inter-relations that aggravate AD are being discovered including pre-existing diseases and exposure to other pathogens. Simultaneously, new therapeutic strategies involving modulation of gene expression through targeted delivery or modulation with light, harnessing the immune response to promote clearance of amyloid deposits, introduction of stem cells and extracellular vesicles to replace the destroyed neurons, exploring new therapeutic molecules from plant, marine and biological sources delivered in the free state or through nanoparticles and use of non-pharmacological interventions like music, transcranial stimulation and yoga. Polypharmacology approaches involving combination of therapeutic agents are also under active investigation for superior therapeutic outcomes. This review elaborates on various disease-causing factors, their underlying mechanisms, the inter-play between different disease-causing players, and emerging therapeutic options including those under clinical trials, for treatment of AD. The challenges involved in AD therapy and the way forward have also been discussed.

Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer's Disease

Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease

Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges

Neuromodulation in Alzheimer’s Disease in the Therapy Process

Application of nanotechnology for diagnosis of Alzheimer's disease

Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer's Disease research

Recent Advances: Decoding Alzheimer’s Disease with Stem Cells

Emerging nanotechnology for Alzheimer's disease: From detection to treatment

Alzheimer's Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions

The Application of Neuromodulation Technology in Cognitive Impairment of Alzheimer's Disease

Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimer's Diseases

Emerging Nanotechnology for Treatment of Alzheimer’s and Parkinson’s Disease

Emerging Nanotechnology for Treatment of Alzheimer's and Parkinson's Disease

Current approaches in the treatment of Alzheimer's disease

Recent trends in treatment strategies for Alzheimer's disease and the challenges: A topical advancement

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges

Neurorestorative Strategies for Alzheimer's Disease.

Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective

Recent Advances in the Treatment and Management of Alzheimer’s Disease: A Precision Medicine Perspective

An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy.

Mechanistic insights and emerging therapeutic stratagems for Alzheimer's disease